Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF384
|
ENSG00000126746.13 | zinc finger protein 384 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF384 | hg19_v2_chr12_-_6798025_6798102 | 0.34 | 5.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_101988627 | 2.35 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr2_+_1418154 | 2.25 |
ENST00000423320.1
ENST00000382198.1 |
TPO
|
thyroid peroxidase |
chr12_+_101988774 | 2.24 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr4_-_159956333 | 2.03 |
ENST00000434826.2
|
C4orf45
|
chromosome 4 open reading frame 45 |
chr7_+_117864708 | 1.98 |
ENST00000357099.4
ENST00000265224.4 ENST00000486422.1 ENST00000417525.1 |
ANKRD7
|
ankyrin repeat domain 7 |
chr6_-_26027480 | 1.97 |
ENST00000377364.3
|
HIST1H4B
|
histone cluster 1, H4b |
chr1_+_156308403 | 1.95 |
ENST00000481479.1
ENST00000368252.1 ENST00000466306.1 ENST00000368251.1 |
TSACC
|
TSSK6 activating co-chaperone |
chr17_+_4487294 | 1.91 |
ENST00000338859.4
|
SMTNL2
|
smoothelin-like 2 |
chr1_-_238649319 | 1.88 |
ENST00000400946.2
|
RP11-371I1.2
|
long intergenic non-protein coding RNA 1139 |
chrX_-_49965663 | 1.84 |
ENST00000376056.2
ENST00000376058.2 ENST00000358526.2 |
AKAP4
|
A kinase (PRKA) anchor protein 4 |
chr20_+_12989895 | 1.73 |
ENST00000450297.1
|
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
chr11_+_27062502 | 1.72 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr6_-_47010061 | 1.70 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
chrX_+_102965835 | 1.66 |
ENST00000319560.6
|
TMEM31
|
transmembrane protein 31 |
chr5_-_101834712 | 1.66 |
ENST00000506729.1
ENST00000389019.3 ENST00000379810.1 |
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1 |
chr5_-_101834617 | 1.60 |
ENST00000513675.1
ENST00000379807.3 |
SLCO6A1
|
solute carrier organic anion transporter family, member 6A1 |
chr6_+_31105426 | 1.58 |
ENST00000547221.1
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1 |
chr7_-_143966381 | 1.55 |
ENST00000487179.1
|
CTAGE8
|
CTAGE family, member 8 |
chr15_+_69373184 | 1.55 |
ENST00000558147.1
ENST00000440444.1 |
LINC00277
|
long intergenic non-protein coding RNA 277 |
chr1_-_185597619 | 1.53 |
ENST00000608417.1
ENST00000436955.1 |
GS1-204I12.1
|
GS1-204I12.1 |
chr2_+_47596287 | 1.51 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
chr6_-_52628271 | 1.51 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
chr11_+_101983176 | 1.51 |
ENST00000524575.1
|
YAP1
|
Yes-associated protein 1 |
chr2_-_118943930 | 1.47 |
ENST00000449075.1
ENST00000414886.1 ENST00000449819.1 |
AC093901.1
|
AC093901.1 |
chr2_+_232457569 | 1.46 |
ENST00000313965.2
|
C2orf57
|
chromosome 2 open reading frame 57 |
chr12_+_48722763 | 1.45 |
ENST00000335017.1
|
H1FNT
|
H1 histone family, member N, testis-specific |
chr12_-_53298841 | 1.43 |
ENST00000293308.6
|
KRT8
|
keratin 8 |
chr1_+_169079823 | 1.42 |
ENST00000367813.3
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr2_-_217560248 | 1.41 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chrY_-_20935572 | 1.39 |
ENST00000382852.1
ENST00000344884.4 ENST00000304790.3 |
HSFY2
|
heat shock transcription factor, Y linked 2 |
chr8_-_133637624 | 1.39 |
ENST00000522789.1
|
LRRC6
|
leucine rich repeat containing 6 |
chr11_+_27062272 | 1.39 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr16_+_27078219 | 1.39 |
ENST00000418886.1
|
C16orf82
|
chromosome 16 open reading frame 82 |
chr3_-_172859017 | 1.38 |
ENST00000351008.3
|
SPATA16
|
spermatogenesis associated 16 |
chr19_+_56368803 | 1.38 |
ENST00000587891.1
|
NLRP4
|
NLR family, pyrin domain containing 4 |
chr1_-_205391178 | 1.34 |
ENST00000367153.4
ENST00000367151.2 ENST00000391936.2 ENST00000367149.3 |
LEMD1
|
LEM domain containing 1 |
chrX_-_132095419 | 1.32 |
ENST00000370836.2
ENST00000521489.1 |
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2 |
chr11_+_27062860 | 1.32 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr1_+_38022572 | 1.31 |
ENST00000541606.1
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr7_+_117864815 | 1.27 |
ENST00000433239.1
|
ANKRD7
|
ankyrin repeat domain 7 |
chr17_-_10325261 | 1.26 |
ENST00000403437.2
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal |
chrX_-_110513703 | 1.23 |
ENST00000324068.1
|
CAPN6
|
calpain 6 |
chr12_-_7245125 | 1.21 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr7_+_134551583 | 1.19 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr21_-_10990888 | 1.19 |
ENST00000298232.7
|
TPTE
|
transmembrane phosphatase with tensin homology |
chr6_-_46620522 | 1.18 |
ENST00000275016.2
|
CYP39A1
|
cytochrome P450, family 39, subfamily A, polypeptide 1 |
chr20_+_12989822 | 1.18 |
ENST00000378194.4
|
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
chr1_-_120311517 | 1.18 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
chrX_-_142605301 | 1.17 |
ENST00000370503.2
|
SPANXN3
|
SPANX family, member N3 |
chr16_+_80574854 | 1.17 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
chr3_+_46618727 | 1.17 |
ENST00000296145.5
|
TDGF1
|
teratocarcinoma-derived growth factor 1 |
chr2_-_177502659 | 1.16 |
ENST00000295549.4
|
AC017048.3
|
long intergenic non-protein coding RNA 1116 |
chr5_+_137203465 | 1.13 |
ENST00000239926.4
|
MYOT
|
myotilin |
chr7_+_143268894 | 1.12 |
ENST00000420911.2
|
CTAGE15
|
cTAGE family member 15 |
chr11_+_125658006 | 1.12 |
ENST00000445202.1
|
PATE3
|
prostate and testis expressed 3 |
chrX_+_105937068 | 1.11 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr9_+_92219919 | 1.10 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr2_+_79252822 | 1.10 |
ENST00000272324.5
|
REG3G
|
regenerating islet-derived 3 gamma |
chr21_-_43735628 | 1.09 |
ENST00000291525.10
ENST00000518498.1 |
TFF3
|
trefoil factor 3 (intestinal) |
chr1_+_156308245 | 1.08 |
ENST00000368253.2
ENST00000470342.1 ENST00000368254.1 |
TSACC
|
TSSK6 activating co-chaperone |
chr20_-_29978383 | 1.08 |
ENST00000339144.3
ENST00000376321.3 |
DEFB119
|
defensin, beta 119 |
chr19_-_8809139 | 1.08 |
ENST00000324436.3
|
ACTL9
|
actin-like 9 |
chrX_+_105192423 | 1.08 |
ENST00000540278.1
|
NRK
|
Nik related kinase |
chr7_-_37956409 | 1.08 |
ENST00000436072.2
|
SFRP4
|
secreted frizzled-related protein 4 |
chr17_-_10452929 | 1.07 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
chr4_-_153700864 | 1.07 |
ENST00000304337.2
|
TIGD4
|
tigger transposable element derived 4 |
chr4_+_175839506 | 1.07 |
ENST00000505141.1
ENST00000359240.3 ENST00000445694.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
chr6_+_112375275 | 1.07 |
ENST00000368666.2
ENST00000604763.1 ENST00000230529.5 |
WISP3
|
WNT1 inducible signaling pathway protein 3 |
chr6_-_28321971 | 1.07 |
ENST00000396838.2
ENST00000426434.1 ENST00000434036.1 ENST00000439628.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
chr6_-_166401402 | 1.05 |
ENST00000581850.1
ENST00000444465.1 |
LINC00473
|
long intergenic non-protein coding RNA 473 |
chr2_-_113993020 | 1.05 |
ENST00000465084.1
|
PAX8
|
paired box 8 |
chr5_-_150948414 | 1.04 |
ENST00000261800.5
|
FAT2
|
FAT atypical cadherin 2 |
chr8_-_39695719 | 1.04 |
ENST00000347580.4
ENST00000379853.2 ENST00000521880.1 |
ADAM2
|
ADAM metallopeptidase domain 2 |
chr12_+_56075330 | 1.04 |
ENST00000394252.3
|
METTL7B
|
methyltransferase like 7B |
chr12_-_7245018 | 1.04 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr8_+_13424352 | 1.04 |
ENST00000297324.4
|
C8orf48
|
chromosome 8 open reading frame 48 |
chr3_-_112329110 | 1.03 |
ENST00000479368.1
|
CCDC80
|
coiled-coil domain containing 80 |
chr14_-_60952739 | 1.03 |
ENST00000555476.1
ENST00000321731.3 |
C14orf39
|
chromosome 14 open reading frame 39 |
chr2_+_79252804 | 1.03 |
ENST00000393897.2
|
REG3G
|
regenerating islet-derived 3 gamma |
chr9_-_107754034 | 1.03 |
ENST00000457720.1
|
RP11-217B7.3
|
RP11-217B7.3 |
chr2_-_183291741 | 1.03 |
ENST00000351439.5
ENST00000409365.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr1_+_38022513 | 1.02 |
ENST00000296218.7
|
DNALI1
|
dynein, axonemal, light intermediate chain 1 |
chr10_-_91316398 | 1.02 |
ENST00000475682.1
|
SLC16A12
|
solute carrier family 16, member 12 |
chrX_-_104465358 | 1.02 |
ENST00000372578.3
ENST00000372575.1 ENST00000413579.1 |
TEX13A
|
testis expressed 13A |
chr2_-_211168332 | 1.01 |
ENST00000341685.4
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast |
chr15_+_63050785 | 1.01 |
ENST00000472902.1
|
TLN2
|
talin 2 |
chr22_-_22901477 | 1.00 |
ENST00000420709.1
ENST00000398741.1 ENST00000405655.3 |
PRAME
|
preferentially expressed antigen in melanoma |
chr15_-_54051831 | 0.99 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
chr6_-_52668605 | 0.99 |
ENST00000334575.5
|
GSTA1
|
glutathione S-transferase alpha 1 |
chr8_-_19102999 | 0.99 |
ENST00000517949.1
|
RP11-1080G15.1
|
RP11-1080G15.1 |
chr12_-_7245152 | 0.99 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
chr3_-_58523010 | 0.99 |
ENST00000459701.2
ENST00000302819.5 |
ACOX2
|
acyl-CoA oxidase 2, branched chain |
chr4_+_175839551 | 0.98 |
ENST00000404450.4
ENST00000514159.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
chr4_+_41258786 | 0.97 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
chr3_+_57094469 | 0.97 |
ENST00000334325.1
|
SPATA12
|
spermatogenesis associated 12 |
chr2_-_238322800 | 0.97 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
chr4_+_175839517 | 0.97 |
ENST00000502940.1
ENST00000502305.1 |
ADAM29
|
ADAM metallopeptidase domain 29 |
chr4_-_147043058 | 0.97 |
ENST00000512063.1
ENST00000507726.1 |
RP11-6L6.3
|
long intergenic non-protein coding RNA 1095 |
chrX_-_80457385 | 0.97 |
ENST00000451455.1
ENST00000436386.1 ENST00000358130.2 |
HMGN5
|
high mobility group nucleosome binding domain 5 |
chr5_+_140593509 | 0.97 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
chr18_+_47088401 | 0.97 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
chr5_-_74532696 | 0.96 |
ENST00000506364.2
ENST00000274361.3 |
ANKRD31
|
ankyrin repeat domain 31 |
chr5_+_134303591 | 0.96 |
ENST00000282611.6
|
CATSPER3
|
cation channel, sperm associated 3 |
chr1_+_47137445 | 0.96 |
ENST00000569393.1
ENST00000334122.4 ENST00000415500.1 |
TEX38
|
testis expressed 38 |
chr19_-_50266580 | 0.96 |
ENST00000246801.3
|
TSKS
|
testis-specific serine kinase substrate |
chrX_+_114524275 | 0.95 |
ENST00000371921.1
ENST00000451986.2 ENST00000371920.3 |
LUZP4
|
leucine zipper protein 4 |
chr2_+_234637754 | 0.95 |
ENST00000482026.1
ENST00000609767.1 |
UGT1A3
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A3 UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr12_+_101962128 | 0.95 |
ENST00000550514.1
|
MYBPC1
|
myosin binding protein C, slow type |
chr20_+_12989596 | 0.95 |
ENST00000434210.1
ENST00000399002.2 |
SPTLC3
|
serine palmitoyltransferase, long chain base subunit 3 |
chr8_-_124741451 | 0.94 |
ENST00000520519.1
|
ANXA13
|
annexin A13 |
chr5_-_41261540 | 0.94 |
ENST00000263413.3
|
C6
|
complement component 6 |
chr3_-_196242233 | 0.94 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
chr1_+_201979645 | 0.94 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chrX_+_23928500 | 0.93 |
ENST00000435707.1
|
CXorf58
|
chromosome X open reading frame 58 |
chrX_+_151081351 | 0.93 |
ENST00000276344.2
|
MAGEA4
|
melanoma antigen family A, 4 |
chr17_-_15469590 | 0.93 |
ENST00000312127.2
|
CDRT1
|
CMT duplicated region transcript 1; Uncharacterized protein |
chr21_+_40817749 | 0.93 |
ENST00000380637.3
ENST00000380634.1 ENST00000458295.1 ENST00000440288.2 ENST00000380631.1 |
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
chr9_-_35689900 | 0.92 |
ENST00000378300.5
ENST00000329305.2 ENST00000360958.2 |
TPM2
|
tropomyosin 2 (beta) |
chr8_+_92114873 | 0.92 |
ENST00000343709.3
ENST00000448384.2 |
LRRC69
|
leucine rich repeat containing 69 |
chr19_+_42349092 | 0.92 |
ENST00000269945.3
ENST00000596258.1 |
DMRTC2
|
DMRT-like family C2 |
chr20_+_238357 | 0.92 |
ENST00000382376.3
|
DEFB132
|
defensin, beta 132 |
chr17_+_4487816 | 0.91 |
ENST00000389313.4
|
SMTNL2
|
smoothelin-like 2 |
chr19_+_8953269 | 0.91 |
ENST00000305625.2
|
MBD3L1
|
methyl-CpG binding domain protein 3-like 1 |
chr2_+_149974684 | 0.91 |
ENST00000450639.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
chr21_-_28338732 | 0.91 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr21_-_34542541 | 0.91 |
ENST00000451980.2
|
C21orf54
|
chromosome 21 open reading frame 54 |
chr10_+_127661942 | 0.91 |
ENST00000417114.1
ENST00000445510.1 ENST00000368691.1 |
FANK1
|
fibronectin type III and ankyrin repeat domains 1 |
chrX_+_37850026 | 0.90 |
ENST00000341016.3
|
CXorf27
|
chromosome X open reading frame 27 |
chr7_-_126892303 | 0.90 |
ENST00000358373.3
|
GRM8
|
glutamate receptor, metabotropic 8 |
chr7_-_88425025 | 0.90 |
ENST00000297203.2
|
C7orf62
|
chromosome 7 open reading frame 62 |
chr11_+_114168085 | 0.90 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr12_-_54867352 | 0.90 |
ENST00000305879.5
|
GTSF1
|
gametocyte specific factor 1 |
chr6_-_24358264 | 0.90 |
ENST00000378454.3
|
DCDC2
|
doublecortin domain containing 2 |
chrX_+_49216659 | 0.90 |
ENST00000415752.1
|
GAGE12I
|
G antigen 12I |
chr5_+_140514782 | 0.89 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
chr12_-_7245080 | 0.89 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr12_+_110011571 | 0.88 |
ENST00000539696.1
ENST00000228510.3 ENST00000392727.3 |
MVK
|
mevalonate kinase |
chr20_+_207892 | 0.88 |
ENST00000246105.4
|
DEFB129
|
defensin, beta 129 |
chr16_+_68678892 | 0.88 |
ENST00000429102.2
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr5_-_35938674 | 0.88 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
chr4_-_150736962 | 0.88 |
ENST00000502345.1
ENST00000510975.1 ENST00000511993.1 |
RP11-526A4.1
|
RP11-526A4.1 |
chr8_-_7343922 | 0.88 |
ENST00000335479.2
|
DEFB106B
|
defensin, beta 106B |
chr15_+_22382382 | 0.88 |
ENST00000328795.4
|
OR4N4
|
olfactory receptor, family 4, subfamily N, member 4 |
chr4_-_110723134 | 0.88 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
chr1_-_198509804 | 0.87 |
ENST00000489986.1
ENST00000367382.1 |
ATP6V1G3
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 |
chr4_+_186347388 | 0.87 |
ENST00000511138.1
ENST00000511581.1 |
C4orf47
|
chromosome 4 open reading frame 47 |
chr6_-_169364429 | 0.87 |
ENST00000444586.1
|
RP3-495K2.3
|
RP3-495K2.3 |
chr12_-_48963829 | 0.87 |
ENST00000301046.2
ENST00000549817.1 |
LALBA
|
lactalbumin, alpha- |
chr5_+_137203557 | 0.87 |
ENST00000515645.1
|
MYOT
|
myotilin |
chr5_+_127039075 | 0.86 |
ENST00000514853.2
|
CTC-228N24.1
|
CTC-228N24.1 |
chr9_-_95166976 | 0.86 |
ENST00000447356.1
|
OGN
|
osteoglycin |
chr2_-_219906220 | 0.85 |
ENST00000458526.1
ENST00000409865.3 ENST00000410037.1 ENST00000457968.1 ENST00000436631.1 ENST00000341552.5 ENST00000441968.1 ENST00000295729.2 |
CCDC108
|
coiled-coil domain containing 108 |
chr12_+_100867486 | 0.85 |
ENST00000548884.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
chr7_-_143454789 | 0.85 |
ENST00000470691.2
|
CTAGE6
|
CTAGE family, member 6 |
chr19_-_55653259 | 0.85 |
ENST00000593194.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr1_-_79472365 | 0.85 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
chr18_-_53804580 | 0.85 |
ENST00000590484.1
ENST00000589293.1 ENST00000587904.1 ENST00000591974.1 |
RP11-456O19.4
|
RP11-456O19.4 |
chr8_-_40200877 | 0.85 |
ENST00000521030.1
|
CTA-392C11.1
|
CTA-392C11.1 |
chr22_-_40289759 | 0.84 |
ENST00000325157.6
|
ENTHD1
|
ENTH domain containing 1 |
chr5_-_135290651 | 0.84 |
ENST00000522943.1
ENST00000514447.2 |
LECT2
|
leukocyte cell-derived chemotaxin 2 |
chr12_+_100867733 | 0.84 |
ENST00000546380.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
chr9_-_95166841 | 0.84 |
ENST00000262551.4
|
OGN
|
osteoglycin |
chr12_+_100867694 | 0.84 |
ENST00000392986.3
ENST00000549996.1 |
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
chr1_-_100643765 | 0.83 |
ENST00000370137.1
ENST00000370138.1 ENST00000342895.3 |
LRRC39
|
leucine rich repeat containing 39 |
chr3_+_94657016 | 0.83 |
ENST00000462219.1
|
LINC00879
|
long intergenic non-protein coding RNA 879 |
chr11_-_3663502 | 0.83 |
ENST00000359918.4
|
ART5
|
ADP-ribosyltransferase 5 |
chr14_+_101361107 | 0.83 |
ENST00000553584.1
ENST00000554852.1 |
MEG8
|
maternally expressed 8 (non-protein coding) |
chr12_-_111358372 | 0.83 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chr1_-_182921119 | 0.83 |
ENST00000423786.1
|
SHCBP1L
|
SHC SH2-domain binding protein 1-like |
chr6_+_76599809 | 0.82 |
ENST00000430435.1
|
MYO6
|
myosin VI |
chr22_-_29107919 | 0.82 |
ENST00000434810.1
ENST00000456369.1 |
CHEK2
|
checkpoint kinase 2 |
chr12_+_32638897 | 0.82 |
ENST00000531134.1
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
chr1_+_43637996 | 0.82 |
ENST00000528956.1
ENST00000529956.1 |
WDR65
|
WD repeat domain 65 |
chrX_+_37026432 | 0.82 |
ENST00000358047.3
|
FAM47C
|
family with sequence similarity 47, member C |
chr10_-_75118611 | 0.82 |
ENST00000355577.3
ENST00000394865.1 ENST00000310715.3 ENST00000401621.2 |
TTC18
|
tetratricopeptide repeat domain 18 |
chr6_-_31846744 | 0.82 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr13_-_103019744 | 0.82 |
ENST00000437115.2
|
FGF14-IT1
|
FGF14 intronic transcript 1 (non-protein coding) |
chr2_+_48844937 | 0.82 |
ENST00000448460.1
ENST00000437125.1 ENST00000430487.2 |
GTF2A1L
|
general transcription factor IIA, 1-like |
chr17_+_68101117 | 0.81 |
ENST00000587698.1
ENST00000587892.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr6_+_27215471 | 0.81 |
ENST00000421826.2
|
PRSS16
|
protease, serine, 16 (thymus) |
chrX_-_140336629 | 0.81 |
ENST00000358993.2
|
SPANXC
|
SPANX family, member C |
chr2_+_11696464 | 0.81 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chr9_-_7961080 | 0.81 |
ENST00000435444.1
|
RP11-29B9.2
|
RP11-29B9.2 |
chr4_-_135122903 | 0.81 |
ENST00000421491.3
ENST00000529122.2 |
PABPC4L
|
poly(A) binding protein, cytoplasmic 4-like |
chr1_-_240906911 | 0.81 |
ENST00000431139.2
|
RP11-80B9.4
|
RP11-80B9.4 |
chrY_+_20708557 | 0.81 |
ENST00000307393.2
ENST00000309834.4 ENST00000382856.2 |
HSFY1
|
heat shock transcription factor, Y-linked 1 |
chr6_-_49755019 | 0.81 |
ENST00000304801.3
|
PGK2
|
phosphoglycerate kinase 2 |
chr12_+_85430110 | 0.80 |
ENST00000393212.3
ENST00000393217.2 |
LRRIQ1
|
leucine-rich repeats and IQ motif containing 1 |
chr8_+_58106143 | 0.80 |
ENST00000521653.1
ENST00000518556.1 |
RP11-513O17.2
|
RP11-513O17.2 |
chr8_-_82443613 | 0.80 |
ENST00000360464.4
|
FABP12
|
fatty acid binding protein 12 |
chr6_+_28227063 | 0.80 |
ENST00000343684.3
|
NKAPL
|
NFKB activating protein-like |
chr12_-_47219733 | 0.80 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
chr7_+_45927956 | 0.80 |
ENST00000275525.3
ENST00000457280.1 |
IGFBP1
|
insulin-like growth factor binding protein 1 |
chr3_-_189840223 | 0.80 |
ENST00000427335.2
|
LEPREL1
|
leprecan-like 1 |
chr1_+_110009215 | 0.80 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr12_+_48876275 | 0.79 |
ENST00000314014.2
|
C12orf54
|
chromosome 12 open reading frame 54 |
chr6_+_46661575 | 0.79 |
ENST00000450697.1
|
TDRD6
|
tudor domain containing 6 |
chr11_-_34533257 | 0.79 |
ENST00000312319.2
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
chr18_-_19997878 | 0.79 |
ENST00000391403.2
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1 |
chr7_+_90032667 | 0.79 |
ENST00000496677.1
ENST00000287916.4 ENST00000535571.1 ENST00000394604.1 ENST00000394605.2 |
CLDN12
|
claudin 12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.8 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.6 | 2.5 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.6 | 1.8 | GO:2000612 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.6 | 2.2 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.5 | 2.0 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.5 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.5 | 1.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.4 | 1.3 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.4 | 1.7 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.4 | 2.0 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.4 | 1.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 1.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.4 | 1.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 1.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 4.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.3 | 1.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 2.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.3 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.3 | 1.3 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
0.3 | 0.9 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 0.9 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.3 | 1.2 | GO:0044691 | tooth eruption(GO:0044691) |
0.3 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 2.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 0.8 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.3 | 6.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 1.7 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 0.5 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.3 | 0.8 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) glomerular endothelium development(GO:0072011) |
0.3 | 1.1 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.3 | 1.0 | GO:0090132 | epithelial cell migration(GO:0010631) tissue migration(GO:0090130) epithelium migration(GO:0090132) |
0.3 | 1.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.3 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.7 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.2 | 0.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.2 | 0.7 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.2 | 0.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 1.0 | GO:0001545 | primary ovarian follicle growth(GO:0001545) |
0.2 | 1.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 2.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 1.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.7 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.2 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.6 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.2 | 0.2 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.2 | 1.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.2 | 0.6 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.2 | 1.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 3.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 0.6 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.2 | 1.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.8 | GO:0009956 | radial pattern formation(GO:0009956) |
0.2 | 0.6 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.2 | 0.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.2 | 0.6 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.2 | 0.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.2 | 3.6 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) sinoatrial node cell development(GO:0060931) |
0.2 | 5.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 0.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.5 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.2 | 0.5 | GO:0061570 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
0.2 | 0.5 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 2.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.2 | 0.5 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.2 | 0.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.2 | 1.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 2.4 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.1 | 0.4 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 0.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.6 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.4 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.1 | 0.7 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.8 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
0.1 | 0.5 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.1 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.7 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.4 | GO:0061193 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.1 | 0.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.3 | GO:0071657 | positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
0.1 | 0.6 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.6 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.5 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 0.9 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.1 | 0.4 | GO:1903216 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
0.1 | 2.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.5 | GO:0071306 | cellular response to vitamin E(GO:0071306) pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 2.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.5 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) |
0.1 | 0.6 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
0.1 | 0.3 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.1 | 2.0 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 4.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.5 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.3 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 8.6 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 1.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 2.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.8 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.4 | GO:0010446 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
0.1 | 0.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.3 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.1 | 1.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.4 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.2 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.1 | 0.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 1.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.2 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.1 | 0.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 2.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.7 | GO:0015811 | L-cystine transport(GO:0015811) |
0.1 | 0.5 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 1.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.8 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.3 | GO:1903487 | regulation of lactation(GO:1903487) |
0.1 | 1.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.1 | 0.5 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.1 | 0.7 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.3 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.2 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.1 | 1.1 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.1 | 1.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.8 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.5 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.8 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 1.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.2 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.1 | 1.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.4 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.1 | 2.6 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.3 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 1.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.4 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.4 | GO:0015744 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) succinate transmembrane transport(GO:0071422) |
0.1 | 0.4 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.1 | 0.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.2 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.1 | 0.2 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 2.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.2 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 0.3 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.1 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 1.8 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.5 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 0.3 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.1 | 1.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.2 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.2 | GO:0035938 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) positive regulation of estrogen secretion(GO:2000863) regulation of estradiol secretion(GO:2000864) positive regulation of estradiol secretion(GO:2000866) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.2 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.4 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.1 | 0.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.1 | GO:0036146 | response to mycotoxin(GO:0010046) cellular response to mycotoxin(GO:0036146) |
0.1 | 0.4 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.2 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
0.1 | 0.1 | GO:0017143 | insecticide metabolic process(GO:0017143) |
0.1 | 0.2 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 1.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.6 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.2 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 1.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.8 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.1 | 0.3 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0019860 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) |
0.1 | 0.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.3 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.1 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 1.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.1 | 0.2 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
0.1 | 0.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.1 | 0.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.3 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 1.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.6 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 1.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.6 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.3 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.2 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.0 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 0.6 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.2 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.0 | 0.2 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.0 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.3 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.5 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.0 | 0.2 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.0 | 0.9 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.2 | GO:0022007 | neural plate morphogenesis(GO:0001839) neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.0 | 3.0 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.6 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.2 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.0 | 0.1 | GO:0021544 | subpallium development(GO:0021544) striatum development(GO:0021756) |
0.0 | 10.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.2 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.0 | 0.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.2 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 1.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 1.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.3 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.0 | 0.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 1.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.3 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.0 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.0 | 0.1 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.0 | 0.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.0 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.2 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.0 | 0.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.9 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 1.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.0 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 1.0 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.0 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.0 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 2.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.6 | GO:0051170 | nuclear import(GO:0051170) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.6 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.4 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.0 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.3 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.0 | 0.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 1.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.0 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.0 | 0.1 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.0 | 0.2 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.0 | 0.3 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.4 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.6 | GO:0071773 | BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.0 | 2.3 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.8 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.1 | GO:2000778 | helper T cell enhancement of adaptive immune response(GO:0035397) positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.1 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.0 | 0.1 | GO:0071106 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.0 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.1 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.0 | 1.1 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.0 | 0.3 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.1 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.2 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.4 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.0 | 1.0 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.3 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.4 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.4 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0046368 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.0 | 0.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 13.1 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.2 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) |
0.0 | 0.1 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.0 | 0.1 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.2 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.1 | GO:0061098 | regulation of protein tyrosine kinase activity(GO:0061097) positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.0 | 0.0 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.0 | 1.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0097384 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.1 | GO:1902362 | melanocyte apoptotic process(GO:1902362) |
0.0 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.0 | 0.3 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.4 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.6 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.1 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.3 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.2 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.1 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.1 | GO:2000508 | negative regulation of T-helper 17 cell lineage commitment(GO:2000329) regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.4 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.0 | 0.1 | GO:0030879 | mammary gland development(GO:0030879) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.0 | 0.2 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.4 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.0 | GO:0065001 | cloaca development(GO:0035844) pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric nephron tubule development(GO:0039020) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) specification of axis polarity(GO:0065001) Kupffer's vesicle development(GO:0070121) |
0.0 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.0 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.0 | 0.1 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.0 | 0.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.2 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.0 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.2 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.0 | 0.3 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.0 | 0.1 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.0 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.0 | GO:0060161 | musculoskeletal movement, spinal reflex action(GO:0050883) positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.0 | 0.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.6 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.1 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0001534 | radial spoke(GO:0001534) |
0.4 | 5.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 1.1 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.3 | 1.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 3.9 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.3 | 8.8 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 1.1 | GO:0070985 | TFIIK complex(GO:0070985) |
0.3 | 0.5 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.2 | 1.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.7 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.2 | 3.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.5 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 2.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 1.9 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 4.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 2.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 1.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 1.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 2.4 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 1.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 0.5 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.5 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.3 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.1 | 0.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.7 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.5 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 1.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 1.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.9 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.4 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.2 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.1 | 0.2 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.1 | 1.5 | GO:0001741 | XY body(GO:0001741) |
0.1 | 2.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 2.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.9 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 2.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 4.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 1.1 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 3.0 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 1.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 4.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.5 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 2.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 2.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 1.0 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.6 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.8 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 3.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 2.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 5.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.0 | GO:0030897 | AP-3 adaptor complex(GO:0030123) HOPS complex(GO:0030897) |
0.0 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 7.9 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 1.8 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0031213 | RSF complex(GO:0031213) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 1.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.2 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.1 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 1.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.0 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 0.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 1.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 9.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 1.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.2 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.0 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 1.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.3 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 7.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.9 | GO:0005813 | centrosome(GO:0005813) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.8 | 0.8 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.6 | 2.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.5 | 3.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.5 | 3.9 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.4 | 1.3 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.4 | 1.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.4 | 1.1 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.3 | 1.3 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 1.3 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.3 | 1.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 0.8 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.3 | 0.8 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.3 | 1.8 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.3 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 2.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 1.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 1.0 | GO:1902379 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.2 | 1.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.2 | 6.2 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 1.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 1.6 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.2 | 0.7 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.2 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 1.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 2.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.8 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.2 | 2.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 2.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 0.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.2 | 0.5 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.2 | 0.7 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.2 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 0.3 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.2 | 0.8 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.5 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.2 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.4 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.1 | 3.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 3.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.9 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 1.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.5 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.1 | 1.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.1 | 0.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.1 | 0.6 | GO:0004320 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.1 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.3 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 0.4 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 0.3 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 0.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 1.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.1 | 5.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
0.1 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.3 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.1 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.3 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.4 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0005503 | all-trans retinal binding(GO:0005503) benzaldehyde dehydrogenase activity(GO:0019115) |
0.1 | 0.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 10.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.7 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 4.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.1 | 0.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.4 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.1 | 0.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 1.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.2 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.1 | 0.3 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.2 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.1 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.6 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
0.1 | 0.4 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 0.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 2.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.4 | GO:0017153 | citrate transmembrane transporter activity(GO:0015137) succinate transmembrane transporter activity(GO:0015141) tricarboxylic acid transmembrane transporter activity(GO:0015142) sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.1 | 0.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.2 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.1 | 0.2 | GO:0003973 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.1 | 1.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 1.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.7 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 1.2 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 1.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 0.1 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.2 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.1 | 0.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.4 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 1.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 2.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 2.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.0 | 0.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 2.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.0 | 1.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 8.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.0 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.0 | 0.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 1.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 10.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 1.3 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 2.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.3 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.0 | 0.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.0 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.0 | 0.1 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.1 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.0 | 2.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.0 | 0.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.1 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.0 | 0.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.0 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 1.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 3.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.0 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.0 | 3.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.4 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 2.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 1.5 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.0 | 0.0 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.3 | GO:0042166 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 0.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 1.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.0 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.0 | 0.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 3.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 3.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 2.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 11.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 3.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 4.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 4.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 3.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 4.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 2.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 3.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 3.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 2.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 1.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 4.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 2.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 1.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 2.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 8.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 2.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 2.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 1.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 1.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 1.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 3.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.6 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |